Pelthos Therapeutics Inc

Located in Durham, NC, TrialCard Inc offers end-to-end partnership commercial solutions for life sciences companies, providing insights, data strategy consulting, market access intelligence, patient support services, and more. With a focus on unlocking product value and enhancing patient lives, TrialCard Inc combines proven industry expertise with innovative technology and data analytics. Through integrated commercial solutions, TrialCard Inc guides industry leaders on critical business issues, improves patient outcomes with data analytics programs, and engages healthcare providers strategically to generate leads and educate across the value chain. With a track record of $23 billion in patient savings, supporting 36 million patients, and partnering with 500 life sciences companies, TrialCard Inc is a trusted partner in the pharmaceutical commercialization space.Generated from the website

Glaxosmithkline (GSK) is a global pharmaceutical company headquartered in Durham, NC, dedicated to developing innovative medicines and vaccines to enhance global health. Their research and development efforts focus on therapeutic areas including oncology, respiratory, and specialty medicines, aiming to provide cutting-edge treatments to patients worldwide. GSK places a strong emphasis on diversity, equity, and inclusion, striving to create a positive impact on the world's health. Committed to improving global health, GSK's mission is to bring about positive change through their dedication to research and development of life-saving medications and vaccines. Generated from the website

Evecxia Therapeutics, Inc., based in Durham, NC, is a pioneering pharmaceutical company dedicated to improving the lives of individuals with mental illness. With a focus on serotonin synthesis amplification, Evecxia is at the forefront of developing innovative drug delivery technologies to harness the therapeutic potential of 5-hydroxytryptamine (5-HTP), the natural precursor of serotonin. By amplifying the production of natural brain serotonin, Evecxia aims to provide more effective treatment options for individuals suffering from mental illnesses that are not adequately addressed by current therapies. Driven by the mission to help individuals lead fuller and more meaningful lives, Evecxia Therapeutics is committed to addressing the negative impact of mental illness on various aspects of life, including emotional well-being, work performance, and relationships. By leveraging their expertise in serotonin neurotransmission, Evecxia is developing novel drug candidates that have shown promise in clinical settings, particularly as adjunctive therapies for depression. Through their innovative approach, Evecxia Therapeutics aims to revolutionize the treatment of mental illnesses and provide new hope for those in need.Generated from the website